导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -28.73% | 331/350 |
| 近一周 | -1.97% | 99/358 |
| 近一月 | -6.27% | 254/358 |
| 近一季 | -5.88% | 224/358 |
| 近半年 | -18.78% | 334/354 |
| 近一年 | -36.00% | 326/345 |
| 近两年 | 4.60% | 277/310 |
| 近三年 | 4.01% | 184/242 |
| 成立以来 | 0.34% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-18.98% 339/360 |
-15.58% 349/366 |
- - |
- - |
| 2025 | 26.36% 59/358 |
22.77% 28/340 |
-3.74% 312/348 |
25.35% 32/354 |
-14.70% 263/358 |
| 2024 | 23.72% 58/329 |
-2.18% 186/280 |
9.54% 25/310 |
26.80% 69/318 |
-8.94% 270/329 |
| 2023 | -9.14% 147/275 |
4.83% 77/205 |
-9.83% 194/230 |
-2.35% 31/262 |
-1.57% 171/276 |
| 2022 | -15.60% 73/201 |
-17.82% 117/153 |
12.43% 18/164 |
-19.65% 119/189 |
13.68% 64/202 |
| 2021 | -39.58% 97/150 |
-0.84% 233/312 |
-5.26% 301/328 |
-27.05% 316/358 |
-11.83% 134/151 |
| 2020 | 40.41% 11/103 |
-3.91% 58/280 |
28.62% 48/295 |
10.85% 44/299 |
2.49% 228/305 |
| 2019 | - - |
- - |
-4.45% 241/267 |
-1.75% 180/253 |
17.66% 9/266 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 易方达中证海外50ETF联接人民币A VS. 建信富时100指数(QDII)人民币A(539003) |